In KRAS-mutated non-small cell lung cancer, glecirasib exhibits promising efficacy.

Published Date: 03 May 2024

Improved PFS and response rate as compared to authorized KRAS inhibitors are the trend.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Best foot forward—chemo care should include podiatry, say researchers

2.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

3.

High weight and obesity are associated with poor outcomes in leukemia treatment.

4.

Researchers discover that children who survive cancer have socioeconomic challenges.

5.

Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot